Literature DB >> 12530977

Dramatically increased rearrangement and peripheral representation of Vbeta14 driven by the 3'Dbeta1 recombination signal sequence.

Cherry Wu1, Craig H Bassing, David Jung, Barbara B Woodman, Dan Foy, Frederick W Alt.   

Abstract

V(D)J recombination is targeted by short recombination signal (RS) sequences that are relatively conserved but exhibit natural sequence variations. To evaluate the potential of RS sequence variations to determine the primary and peripheral TCRbeta repertoire, we generated mice containing specific replacement of the endogenous Vbeta14 RS with the 3'Dbeta1 RS (Vbeta14/3'DbetaRS). These mice exhibited a dramatic increase in Vbeta14(+) thymocyte numbers at the expense of thymocytes expressing other Vbetas. In addition, the percentage of peripheral Vbeta14(+) alphabeta T lymphocytes was similarly increased. Strikingly, this altered Vbeta repertoire resulted predominantly from a higher relative level of primary Vbeta14/3'DbetaRS rearrangement to DbetaJbeta complexes, despite the ability of the 3'Dbeta1 RS to break B12/23 restriction and allow direct rearrangement of Vbeta14/3'DbetaRS to Jbeta segments.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12530977     DOI: 10.1016/s1074-7613(02)00515-0

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  20 in total

1.  Productive coupling of accessible Vbeta14 segments and DJbeta complexes determines the frequency of Vbeta14 rearrangement.

Authors:  Sheila Ranganath; Andrea C Carpenter; Megan Gleason; Albert C Shaw; Craig H Bassing; Frederick W Alt
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

2.  Unifying model for molecular determinants of the preselection Vβ repertoire.

Authors:  Suhasni Gopalakrishnan; Kinjal Majumder; Alexander Predeus; Yue Huang; Olivia I Koues; Jiyoti Verma-Gaur; Salvatore Loguercio; Andrew I Su; Ann J Feeney; Maxim N Artyomov; Eugene M Oltz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-05       Impact factor: 11.205

3.  Intra-Vκ Cluster Recombination Shapes the Ig Kappa Locus Repertoire.

Authors:  Kenta Shinoda; Yaakov Maman; Andres Canela; David G Schatz; Ferenc Livak; André Nussenzweig
Journal:  Cell Rep       Date:  2019-12-24       Impact factor: 9.423

4.  RAG1-mediated ubiquitylation of histone H3 is required for chromosomal V(D)J recombination.

Authors:  Zimu Deng; Haifeng Liu; Xiaolong Liu
Journal:  Cell Res       Date:  2015-01-09       Impact factor: 25.617

5.  Single-molecule analysis of RAG-mediated V(D)J DNA cleavage.

Authors:  Geoffrey A Lovely; Robert C Brewster; David G Schatz; David Baltimore; Rob Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

6.  The ataxia telangiectasia mutated and cyclin D3 proteins cooperate to help enforce TCRβ and IgH allelic exclusion.

Authors:  Natalie C Steinel; Megan R Fisher; Katherine S Yang-Iott; Craig H Bassing
Journal:  J Immunol       Date:  2014-08-15       Impact factor: 5.422

7.  Noncore RAG1 regions promote Vβ rearrangements and αβ T cell development by overcoming inherent inefficiency of Vβ recombination signal sequences.

Authors:  Julie E Horowitz; Craig H Bassing
Journal:  J Immunol       Date:  2014-01-10       Impact factor: 5.422

8.  Evolutionarily conserved pattern of gene segment usage within the mammalian TCRbeta locus.

Authors:  Ferenc Livák
Journal:  Immunogenetics       Date:  2003-07-04       Impact factor: 2.846

9.  Assembled DJ beta complexes influence TCR beta chain selection and peripheral V beta repertoire.

Authors:  Andrea C Carpenter; Katherine S Yang-Iott; Linda H Chao; Beth Nuskey; Scott Whitlow; Frederick W Alt; Craig H Bassing
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

10.  Initiation of V(D)J recombination by Dbeta-associated recombination signal sequences: a critical control point in TCRbeta gene assembly.

Authors:  Don-Marc Franchini; Touati Benoukraf; Sébastien Jaeger; Pierre Ferrier; Dominique Payet-Bornet
Journal:  PLoS One       Date:  2009-02-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.